BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37528490)

  • 1. Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer.
    Wu F; Wang M; Zhong T; Xiao C; Chen X; Huang Y; Wu M; Yu J; Chen D
    Exp Hematol Oncol; 2023 Aug; 12(1):67. PubMed ID: 37528490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer.
    Wittwer NL; Staudacher AH; Liapis V; Cardarelli P; Warren H; Brown MP
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer.
    Tian A; Wu T; Zhang Y; Chen J; Sha J; Xia W
    Cell Oncol (Dordr); 2023 Dec; 46(6):1855-1870. PubMed ID: 37610690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular stomatitis virus sensitizes immunologically cold tumors to checkpoint blockade by inducing pyroptosis.
    Lin J; Liu F; Gao F; Chen Y; Wang R; Wang X; Li Y; Li Q; Sun S; Li Z; Lan Y; Lu H; Guo W; Du L; Gao F; Song D; Zhao K; Guan J; He W
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166538. PubMed ID: 36096276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis.
    Gong C; Mu H; Luo J; Zhang R; Hu D; Chen Z; Fang C; Chen Z; Zhu X; Yao C; Wang L; Zhou Y; Zhao W; Zhu S
    J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38456763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response.
    Xu H; Zhang D; Wei R; Zhou Y; Dai G; Li J; Sun Y; Li F; Xi L
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis.
    Xuzhang W; Lu T; Jin W; Yu Y; Li Z; Shen L; Niu X; Ai X; Xia L; Lu S
    Int J Biol Sci; 2024; 20(2):537-553. PubMed ID: 38169676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
    Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles.
    Hu Y; Liu Y; Zong L; Zhang W; Liu R; Xing Q; Liu Z; Yan Q; Li W; Lei H; Liu X
    Cell Death Dis; 2023 Dec; 14(12):836. PubMed ID: 38104141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
    Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
    J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
    Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
    Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpinumisoflavone triggers GSDME-dependent pyroptosis in esophageal squamous cell carcinomas.
    Zhang B; Zhu WY; Tian H; Zhang HR
    Anat Rec (Hoboken); 2021 Feb; 304(2):323-332. PubMed ID: 32396690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer.
    Zhou Y; Zhang W; Wang B; Wang P; Li D; Cao T; Zhang D; Han H; Bai M; Wang X; Zhao X; Lu Y
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38429070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer.
    Jiang M; Qi L; Li L; Li Y
    Cell Death Discov; 2020; 6():112. PubMed ID: 33133646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic Acid-Functionalized Pyroptosis Nanotuner for Epigenetic Regulation and Enhanced Cancer Immunotherapy.
    Hu J; You Y; Zhu L; Zhang J; Song Y; Lu J; Xu X; Wu X; Huang X; Xu X; Du Y
    Small; 2024 Mar; 20(10):e2306905. PubMed ID: 37880861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
    Wu F; Dai X; Gan W; Wan L; Li M; Mitsiades N; Wei W; Ding Q; Zhang J
    Cancer Lett; 2017 Jan; 385():207-214. PubMed ID: 27780719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis.
    Ye F; Zhang W; Fan C; Dong J; Peng M; Deng W; Zhang H; Yang L
    J Transl Med; 2023 Sep; 21(1):606. PubMed ID: 37679782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobaplatin Induces Pyroptosis in Cervical Cancer Cells via the Caspase-3/GSDME Pathway.
    Chen J; Ge L; Shi X; Liu J; Ruan H; Heng D; Ye C
    Anticancer Agents Med Chem; 2022; 22(11):2091-2097. PubMed ID: 34666646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
    Ma Z; Zhang W; Dong B; Xin Z; Ji Y; Su R; Shen K; Pan J; Wang Q; Xue W
    Theranostics; 2022; 12(11):4965-4979. PubMed ID: 35836810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.